Industries

Biotechnology - Industry

Acronym
Biotech

An industry focused on the manipulation of living organisms to create commercial products, Biotechnology has been a fast-growing scientific industry refined to create novel drugs and pest-resistant crops. As Biotechnology became intrinsic to many aspects of modern life, it does not only include applications in fields that involve the living, but any other field where the information obtained from the biological aspect of an organism can be applied. Other types of Biotechnology includes Medical Biotechnology with vaccines and antibiotics, and Agricultural Biotechnology with plants and crops.

Entities

AIM ImmunoTech
Accumulate
Ahrvo Comply
Apeiron Investment Group
Asclepia Capital
B Capital Group
Corbin Advisors
Dichotomy Capital
ENDRA Life Sciences
Fifty Years
HOF Capital
Healthspan Capital
Money Morning
OrbiMed Advisors
PINK Simplify Health Care ETF
RagingBull
Seven Figure Publishing
Singularity University
Streetwise Reports
The Arora Report

People

Anirvan Ghosh
Anish Mohammed
Ash Carter
Aubrey de Grey
Ben Morris
Ben Samaroo
Bhavneesh Sharma
Bill Patalon
Bret Jensen
Charles Li
Chris Wood
Christian Olsen
Damien Conover
Dave Lashmet
David Eifrig
Edan Yago
Edmund Ingham
Eric Schadt
Ernie Tremblay
Frank Angella
Hadil Es-Sbai
Heather Brilliant
Hung Tran
Jack Forehand
Jake Weber
Jay Lichter
Jean Hynes
Josh Williams
Josh Wolfe
Juliette Morgan
Kyle Dennis
Michael Murphy
Mike Taylor
Nate Pile
Patrick Cox
Safi Bahcall
Sang Lee
Sebastian Brunemeier
Seth Merrin
Steve Sjuggerud
Terry Chrisomalis
Thomas Equels

Publications

BAD BEAT Investing
Bio-Technology Profit Alliance
Biotech Analysis Central
Biotech Gems
Biotech Millionaire
Breakthrough Technology Alert
Catalyst Trader
DailyWealth Trader
Disruption Investor
Early Stage Trader
Exponential Tech Investor
FDA Trader
GameChangers
Haggerston BioHealth
Healthy Returns
Investing News Network
Lightning Trend Trader
Microcap Insider
Money Morning
Nexus-9 Network
Nova X Report
Radical Technology Profits
The Biotech Forum
The Biotech Trader Handbook
The Buyback Letter Standard Edition
The Triumph of Value Investing
Transformational Technology Alert
Vasuda Healthcare Analytics
Wall Street’s Best Investments

  • Biotech are notorious difficult to value -often they are pre revenue, but on the verge
  • When the broader market goes up, biotech can move explosively upward